Request a document copy: Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States medicare population

all files (of this document) in restricted access
the file(s) you requested
Cancel